General Information of Drug (ID: DML9Z8D)

Drug Name
Autologous T-lymphocyte cell therapy
Synonyms Autologous T-lymphocyte cell therapy (G250-scFV-transduced, renal cell carcinoma)
Indication
Disease Entry ICD 11 Status REF
Peripheral vascular disease BD4Z Phase 2 [1]
Cross-matching ID
TTD ID
D07TYM

References

1 Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook. Cancer J. 2012 Mar-Apr;18(2):160-75.